Latent diffusion model for H&E-to-IHC stain transfer, dual-conditioned on pathology foundation-model embeddings, covering HER2, Ki67, ER, and PR.
No providers recorded yet. Browse all providers
HistDiST is a latent diffusion framework for translating H&E-stained histology into immunohistochemistry (IHC), developed by Erik Großkopf, Valay Bundele, Mehran Hosseinzadeh, and Hendrik Lensch at the University of Tübingen. H&E is cheap and universally acquired but carries no molecular specificity; IHC reveals the marker expression that drives treatment decisions in breast cancer and elsewhere, at substantially greater cost and complexity. Generating the IHC counterpart of an H&E slide computationally has therefore been an active target, historically pursued with GANs, which suffer from unstable training and drift in tissue structure.
HistDiST replaces the GAN with a fine-tuned Stable Diffusion backbone and adds two conditioning signals rather than one. Morphological embeddings from Phikon, a self-supervised pathology transformer trained on 40 million histology tiles, enter through the U-Net's cross-attention layers to supply pathology-relevant semantic context; VAE-encoded H&E latents are concatenated with the noisy input to hold structure in place. The paper further diagnoses two failure modes specific to this task — a brightness bias introduced by conventional diffusion noise schedules, and loss of tissue structure at inference — and fixes both with a rescaled schedule enforcing zero terminal signal-to-noise ratio, v-prediction, and DDIM inversion at sampling time.
Alongside the model the authors introduce Molecular Retrieval Accuracy (MRA), a metric that scores whether a generated IHC patch's embedding retrieves its own ground-truth counterpart among all test-set IHC embeddings, using Prov-GigaPath as the feature extractor. This targets a weakness of FID and SSIM, which reward images that look like IHC without checking whether the molecular content is correct. HistDiST sits alongside UNIStainNet, a GAN-based H&E-to-IHC model trained on the same public benchmarks, MIPHEI-ViT for multiplex immunofluorescence, and PathDiff for conditional histopathology synthesis.
HistDiST fine-tunes Stable Diffusion v1.5 for 500 epochs at batch size 16 with AdamW, a 2e-4 learning rate, 1,000 warmup steps, and cosine decay; v-prediction uses γ = 5, and inference runs 200 DDIM inversion steps followed by 200 denoising steps. Evaluation covers two public paired datasets: MIST, with 1024×1024 H&E patches paired against HER2, Ki67, ER, and PR, roughly 4,000 training and 1,000 test pairs per stain; and BCI, with 3,896 training and 977 test H&E–HER2 pairs. Baselines are CycleGAN, Pix2Pix, PyramidPix2Pix, ASP, and MDCL, plus InstructPix2Pix and ControlNet adapted from the natural-image domain. HistDiST attains the highest MRA across tasks — reported as a 28% improvement on H&E-to-Ki67 and 23% over MDCL on MIST-ER and MIST-HER2 — together with the lowest PHV feature-space distances and the best FID and KID scores. The ablation isolates each component: input conditioning alone preserves structure poorly, v-prediction improves molecular expression patterns and FID, DDIM inversion recovers structure, and Phikon cross-attention adds the final gain.
The intended use is reducing dependence on IHC staining in settings where it is a bottleneck: generating a HER2, Ki67, ER, or PR view from an H&E slide already on the scanner, as a triage step before ordering real stains, or as a way to add marker context to retrospective H&E-only cohorts. Because the tissue in a generated image is inferred rather than measured, it supports research and prioritization rather than diagnosis, and the authors position MRA precisely so that molecular fidelity is judged separately from visual plausibility.
HistDiST is one of the more careful diffusion-based treatments of stain transfer, and its contributions divide cleanly into an architecture (dual conditioning), a set of schedule-level corrections that address concrete artifacts, and a metric that makes molecular fidelity measurable. The scope is bounded: four breast-cancer markers on two public datasets, evaluated against pixel-aligned ground truth, with no external cohort or clinical validation. The work is an arXiv preprint and has not been peer reviewed. Code and trained checkpoints are public, though the repository carries no license file, which leaves reuse terms unresolved.
Much of this page is generated or calculated automatically. Flag anything that looks off and we will re-run it.